$149 first order; $240 every four weeks
Selected landing specifies a 1,000 mg/5 mL vial. Review-stage fees and pharmacy fulfillment affect refunds.
Sprout Health’s NAD+ injection referral offer excludes California.
Independent longevity care comparisons
Explore the evidence, then compare NAD+ injection and sermorelin providers by first payment, renewal and known limitations. Longevity Ranked is an independent comparison site, not a clinic.
Plan and provider finder
5 of 9 audited NAD+ plans show a first plan payment.
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate.
Sprout Health’s NAD+ injection referral offer excludes California.
4 plans have no displayed first payment. Different products, term lengths, supplied quantities and missing fees prevent a cheapest claim.
September 15, 2026; September 19, 2026; September 22, 2026; September 26, 2026; October 5, 2026; October 8, 2026; October 13, 2026; October 27, 2026
Payment table: 11 providers 20 injection plans
September 15, 2026; September 19, 2026; September 22, 2026; September 25, 2026; September 26, 2026; October 5, 2026; October 8, 2026; October 9, 2026; October 13, 2026; October 27, 2026
NAD+ and sermorelin prices
Choose a treatment above or in the table. Compare the advertised rate with the initial plan payment and renewal terms.
Sort by
11 sourced injection plans · USD · Alphabetical provider order. This is not a clinical ranking. Full costs are not verified.
| Provider / product | Advertised rate | Initial plan payment | Renewal evidence |
|---|---|---|---|
| $79.00first month; prepaid plan required | Not verified3-month plan billed in full | Published $149/mo after introductory first month; actual charge schedule must be checked at enrollment | |
| $49.00first month; then $99/month | $49.00introductory first month | $99.00Every 1 month | |
| Luvo HealthNAD+ InjectionSource checked 2026-09-26 | $99.50first 4 weeks; introductory offer | $99.50first 4 weeks | $99.50 for the first four weeks (50% introductory offer); $199 every four weeks from the second delivery. Exact renewal processing date needs confirmation. |
| $139.00first month; introductory offer | $139.00introductory first month | $139 for the first month, then $179 every four weeks while enrolled. Nothing is charged until a clinician prescribes. The page also advertises a $119 monthly average on an annual plan but does not publish that plan's complete upfront charge. | |
| $369.00per advertised 8 to 10-week supply | $369.008 to 10-week supply | PeterMD advertises $369 for an 8 to 10-week NAD+ injection supply with two vials and free shipping; future billing and required-fee terms need confirmation. | |
| $99.00per advertised month; promotional offer | Not verifiedCheckout period not verified | RNK's selected NAD+ injection landing displays $99/month against a crossed-out $269. Its homepage shows a different from-$129/month headline. Neither crossed-out amount nor homepage price establishes this offer's next bill or complete checkout total. | |
| $169.00injection starting rate per advertised month | Not verifiedCheckout period not verified | A monthly starting rate is published; the first bill and exact renewal amount, interval and commitment are not verified. | |
| $149.00first order; four-week renewal | $149.00introductory first order | This landing publishes $149 for the first order and $240 every four weeks afterward. Other Sprout NAD+ landings publish different prices; the selected checkout controls the offer. | |
| $76.00first-month promotion | Not verifiedpromotional first month | The treatment page displays $76 for the first month against a crossed-out $126 and mentions both injection and nasal administration. It does not conclusively assign the amount to an injection checkout or state the renewal charge. | |
| $150.00first-month rate; 3-month prepayment condition | Not verified3-month offer; upfront total not verified | The NAD+ page advertises $150 for the first month, then $200/mo. Its footnote ties the price to a 500 mg (2.5 mL) three-month plan paid upfront or through buy now, pay later. The complete initial charge and later payment schedule are not verified; these monthly headlines do not establish monthly installments. | |
| $199.00per advertised month; partner-pharmacy plan | $199.00monthly subscription | $199.00Every 1 month |
Initial plan payment is the published treatment-term amount, not necessarily a charge at intake. Required extra fees and exact supplied quantities are not fully verified. No row establishes an equivalent dose, duration or result.
Provider offers
Approved partner · source-audited provider
PeterMD publishes NAD+ injection, capsule and sermorelin offers.
The general destination opens PeterMD's longevity catalog. Product buttons below use the exact approved NAD+ injection, NAD+ capsule and sermorelin destinations.
Partner link; we may earn a commission. Editorial order and findings do not change.
Partner links track referrals through Katalys/Revoffers. Broad placements use the longevity catalog; product buttons use the exact approved destination. This relationship does not change comparison order or review findings. Refund and auto-bill policy. Checked September 22, 2026.
Approved partner · source-audited provider
Embody NAD+ and sermorelin: $49.00 first month, then $99.00/month.
The two product pages advertise separate monthly plans. Quantity, the dispensing pharmacy and product-specific state access still need confirmation. The first-month promotion has no published end date; confirm availability and the complete selected order.
Partner link; we may earn a commission. Editorial order and findings do not change.
Partner links track referrals through Katalys/Revoffers and open the exact product page. This relationship does not change comparison order or review findings. Official price source. Checked October 13, 2026.
Approved partner · source-audited provider
Luvo Health: NAD+, sermorelin and a four-week entry term.
NAD+ injection and sermorelin pages advertise $99.50 for the first four weeks, then $199 every four weeks. The NAD+ liquid-drops page separately advertises the same $99.50 first-term price and $199 four-week renewal. Route, supplied quantity and clinical suitability are separate decisions.
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate.
Partner link; we may earn a commission. Editorial order and findings do not change.
Partner links track referrals through Katalys/Revoffers. Broad Luvo placements open its longevity program; treatment pages and product buttons use the exact approved destination. This relationship does not change comparison order or the review findings. Official price source. Checked October 8, 2026.
Partner provider · source-based review
Explore HealthRX’s NAD+ and sermorelin pages.
Our HealthRX review compares the selected NAD+ and sermorelin prices with the payment, pharmacy and refund terms. Final prescription and renewal details still need confirmation. Official catalog source.
Partner links track referrals. Current Katalys terms exclude NAD+ and sermorelin purchases from commission; other qualifying orders may earn us a commission. How links work.

Start with the distinction
NAD+ is involved in cellular energy reactions. Sermorelin signals growth-hormone release. Both appear in the longevity market, but neither a mechanism nor a marketing label proves a longer life.
Know the commitment
Selected landing specifies a 1,000 mg/5 mL vial. Review-stage fees and pharmacy fulfillment affect refunds.
Sprout Health’s NAD+ injection referral offer excludes California.
The page lists 1,000 mg monthly, but mentions injection and nasal routes. Confirm the selected product and later charge.
Labeled partner offers, shown alphabetically. The first-month number is not an equivalent-treatment or outcome ranking.
Two focused buying guides
Learn what the product is, compare the actual costs, then assess a provider. No catch-all anti-aging leaderboard.
11 providers, with promotions and recurring bills kept separate.
8 providers, including short and longer treatment terms.
Popular X vs Y questions
We publish a comparison when people are searching for the distinction, even when only one side has audited providers. Inclusion is not an endorsement.
Compare current compounded sermorelin offers with prescription somatropin by product, FDA status, adult growth hormone deficiency evidence and what a plan price includes.
NMN is a precursor; NAD+ is a coenzyme. Compare supplements and injections, human trial findings, safety limits and what to check before buying.
Compare NAD+ injections and oral drops by product, evidence and cost. See why a proprietary oral-powder trial cannot establish benefits for clinic drops.
Compare sermorelin vs tesamorelin for fat loss and muscle claims, human study results, FDA status and safety. Understand EGRIFTA WR and compounded products.
Sermorelin and ipamorelin use different receptors. Compare human studies, fat-loss and muscle claims, FDA concerns and the limits of combination claims.
Compare sermorelin and CJC-1295 by product identity, duration claims, FDA status and evidence limits. Understand why CJC-1295 forms cannot be grouped together.
Evidence answers readers search for
Each page owns one distinct question, states what the cited research measured and keeps the commercial next step separate from the evidence.
Geref's label dose was 30 mcg/kg nightly, for children. Adult trials used 0.5 to 2 mg. See what 10 online sellers publish on dose, vial strength and schedule.
No FDA-approved NAD+ dose exists, and only 1 of 10 online sellers publishes an injection dose. Compare vial strengths, study doses by route and the evidence.
Review reported sermorelin side effects, study limits, injection reactions and compounded-product risks without treating historical product information as a guarantee.
See which sermorelin benefits small human studies measured, which results were mixed and why mechanism does not prove anti-aging, muscle or fat-loss outcomes.
Compare sermorelin before-and-after marketing with the outcomes, duration and limits of small human studies. No invented timeline, photos or guaranteed transformation.
Compare published NAD+ nasal spray offers, route-specific evidence gaps, prices and provider disclosures. Keep nasal products separate from injections and IV research.
The provider reviews
We read the product pages and the terms together. These are public-source reviews, not hands-on medication tests or clinical endorsements. Every review shows its sources and the details that still need confirmation.
How partner links work Report a changed price or sourceExplore TMates NAD+ . Read the TMates review above for published term prices and unresolved vial details.
All completed provider reviews appear here in alphabetical order. Formats and payment certainty differ; a provider can be reviewed without a verified cash-flow schedule.
Evidence before promises
It describes our subject, not a guaranteed treatment benefit. Compounded drugs are not FDA-approved, and their risks deserve the same attention as their prices. Longevity Ranked helps you compare public information; individual medical decisions belong with a clinician.
FDA: understanding compounded-drug risksRead the evidence guidesOpen a prepared question in your chosen AI assistant.
Opens an external service. Check AI answers against our sources.